Decaphar SRL
2.0 FTEThe score of Decaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -60 % Total assets -2 % Headcount (avg FTE) -13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Decaphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 82,626 € | ||||
| Equity | 316,271 € | ||||
| Cash | 410,252 € | ||||
| EBITDA | 186,206 € | ||||
| Total assets | €1.58m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 08 Aug 2025
- Year ended 31 Dec 2023filed on 27 May 2024
- Year ended 31 Dec 2022filed on 31 May 2023
- Year ended 31 Dec 2021filed on 11 May 2022
Decaphar's financial analysis
- Solvency20.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Decaphar
Decaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0843.302.261
- VAT number
- BE0843302261
- Peppol
- Registered · 0208:0843302261 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jan 2012
- Registered office
- 9700 Oudenaarde
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Decaphar (SRL) has been based in Oudenaarde since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 82,626 € and equity of 316,271 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 20.0%, below the median of its sector (44.2%).
Companies similar to Decaphar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VAN DEN Dwey H. Retail sale of pharmaceutical products Antwerp · balance sheet €1.58m
- Amicus - C Retail sale of pharmaceutical products Antwerp · balance sheet €1.58m
- Pharmacie DE LA Porte DE Ghlin Retail sale of pharmaceutical products Mons · balance sheet €1.59m
- Liephar Retail sale of pharmaceutical products Mettet · balance sheet €1.59m
- Heerse Apotheek Retail sale of pharmaceutical products Heers · balance sheet €1.57m
- Soliena Retail sale of pharmaceutical products Buggenhout · balance sheet €1.57m
- Dekerk Kumtich Retail sale of pharmaceutical products Tienen · balance sheet €1.60m
- Apoteek Goossens Retail sale of pharmaceutical products Wemmel · balance sheet €1.56m
Frequently asked questions about Decaphar
What is the revenue of Decaphar?
Decaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Decaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0843302261 for Decaphar, if the company is VAT-registered. Its company number (CBE) is 0843.302.261.
Where is the registered office of Decaphar?
According to the CBE register, the registered office of Decaphar is in 9700 Oudenaarde.
What is the equity of Decaphar?
At the close of the 2025 financial year, the equity of Decaphar amounts to 316,271 €, a solvency of 20.0% of total assets.
How many people work at Decaphar?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Decaphar?
The register lists 3 active mandates at Decaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Decaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →